BCAT1 and breast carcinoma: BCAT1 activates the mTORC1 pathway to play a pro-oncogenic role in breast and endometrial cancers, while BCAT1 inhibits mitochondrial reactive oxygen species (ROS) production in breast cancer cells (25, 27, 32).